Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Karen E. Skinner"'
Autor:
Rachel Garg, Amy McQueen, Jennifer M. Wolff, Karen E. Skinner, Michelle C. Kegler, Matthew W. Kreuter
Publikováno v:
Preventive Medicine Reports, Vol 27, Iss , Pp 101767- (2022)
Smokers are at greater risk of multiple health conditions that are exacerbated by environmental hazards associated with low housing quality. However, little is known about the prevalence of low housing quality among low-income smokers. Using correlat
Externí odkaz:
https://doaj.org/article/97e2f7bec97f4f8c8cbf8c71dbcaaf02
Autor:
Jan Sieluk, Lee S. Schwartzberg, Santosh Gautam, Whitney C Rhodes, Amin Haiderali, Karen E Skinner, Min Huang
Publikováno v:
Future Oncology. 17:3833-3841
Lay abstract This study included 308 patients with early-stage triple-negative breast cancer treated in the USA at community oncology practices. Patients were female, 18 years or older and diagnosed with stage II, IIIA or IIIB breast cancer between M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d339b4e71ea3529e8e8f5fde021026bd
https://doi.org/10.2217/fon-2021-0531
https://doi.org/10.2217/fon-2021-0531
Autor:
Whitney C Rhodes, Amin Haiderali, Lee S. Schwartzberg, Min Huang, Jan Sieluk, Santosh Gautam, Karen E Skinner
Publikováno v:
Cancer Research. 81:PS13-42
Background: Recurrence is common among patients with early-stage triple-negative breast cancer (ESTNBC). There is minimal real-world evidence describing the patient characteristics and clinical outcomes following recurrence among patients receiving n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::002a7a0d423636aa0510ae888b0b8e8c
https://doi.org/10.1158/1538-7445.sabcs20-ps13-42
https://doi.org/10.1158/1538-7445.sabcs20-ps13-42
Autor:
Min Huang, Whitney C Rhodes, Lee S. Schwartzberg, Santosh Gautam, Jan Sieluk, Karen E Skinner, Amin Haiderali
Publikováno v:
Cancer Research. 80:P2-16
Background: For patients with stage II-III early-stage triple-negative breast cancer (ESTNBC), either neoadjuvant or adjuvant administration of chemotherapy is recommended. There is limited evidence describing the real-world patient characteristics a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3441e9eef0f2f3f8c6ba7ab5875ef646
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-33
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-33
Autor:
Karen E Skinner, Jan Sieluk, Amin Haiderali, Lee S. Schwartzberg, Min Huang, Whitney C Rhodes, Santosh Gautam
Publikováno v:
Cancer Research. 80:P2-16
Background: Standard of care treatment for early-stage triple-negative breast cancer (ESTNBC) is chemotherapy. Minimal research has examined real-world effectiveness outcomes in patients with ESTNBC. Methods: This retrospective observational study ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09dc15dcb71e757b2f4139ea60c9ae3d
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-12
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-12
Autor:
Karen E Skinner, Santosh Gautam, Whitney C Rhodes, Jan Sieluk, Min Huang, Lee S. Schwartzberg, Amin Haiderali
Publikováno v:
Future oncology (London, England). 17(29)
Lay abstract This study included 450 patients with early-stage triple-negative breast cancer treated in the USA at community oncology practices. Patients were female, 18 years or older, diagnosed with stage II, IIIA or IIIB breast cancer between Marc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107fa0a431dd864d9d3da06416b75cd8
https://pubmed.ncbi.nlm.nih.gov/34227400
https://pubmed.ncbi.nlm.nih.gov/34227400
Publikováno v:
The Breast Journal. 26:112-119
Fulvestrant monotherapy is approved for postmenopausal women with hormone receptor-positive, metastatic breast cancer (MBC) who progressed following antiendocrine therapy, or those with hormone receptor-positive, human epidermal receptor 2-negative a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691239792878874e4e40b13006e38f4d
https://doi.org/10.1111/tbj.13492
https://doi.org/10.1111/tbj.13492
Publikováno v:
Cancer Research. 79:P1-10
Background: Age, race, and tumor environment are major contributors in the variance of treatment outcomes in patients (pts) with breast cancer. Few studies have evaluated outcomes in real-world pts to identify high-risk populations. We aimed to compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c1e0112c72ba7829afd4ec32068eca6
https://doi.org/10.1158/1538-7445.sabcs18-p1-10-03
https://doi.org/10.1158/1538-7445.sabcs18-p1-10-03
Publikováno v:
Future oncology (London, England). 17(8)
Aim: This study examined treatment patterns and effectiveness outcomes of patients with metastatic triple-negative breast cancer (mTNBC) from US community oncology centers. Materials & methods: Eligible patients were females, aged ≥18 years, diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9324d9451f6f5983214931c7b8ca63e4
https://pubmed.ncbi.nlm.nih.gov/33207944
https://pubmed.ncbi.nlm.nih.gov/33207944
Publikováno v:
Journal of comparative effectiveness research. 10(2)
Aim: Evaluation of monthly cost during metastatic triple-negative breast cancer (mTNBC) treatment. Patients & methods: Retrospective electronic medical record review of US females aged ≥18 years diagnosed with mTNBC between 1 January 2010 and 31 Ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837b7e35271e2d3f0a5ce8d3e8e02936
https://pubmed.ncbi.nlm.nih.gov/33167695
https://pubmed.ncbi.nlm.nih.gov/33167695